Modeling of senescence-related chemoresistance in ovarian cancer using data analysis and patient-derived organoids

Modeling of senescence-related chemoresistance in ovarian cancer using data analysis and patient-derived organoids

BackgroundOvarian cancer (OC) is a malignant tumor associated with poor prognosis owing to its susceptibility to chemoresistance. Cellular senescence, an irreversible biological state, is intricately linked to chemoresistance in cancer treatment. We developed a senescence-related gene signature for...

Full description

Bibliographic Details
Main Authors:	Xintong Cai, Yanhong Li, Jianfeng Zheng, Li Liu, Zicong Jiao, Jie Lin, Shan Jiang, Xuefen Lin, Yang Sun
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Series:	Frontiers in Oncology
Subjects:	cell senescence chemoresistance ovarian cancer organoid TCGA
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1291559/full

Similar Items

The effects of REG4 expression on chemoresistance of ovarian cancer
by: Li-Wei Xiang, et al.
Published: (2022-10-01)

Ascitis as a unique microenvironment of tumors in ovarian cancer: interaction with prognosis and chemoresistance
by: A. B. Villert, et al.
Published: (2019-07-01)

Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer
by: Alice Gambelli, et al.
Published: (2024-04-01)

Impact of Obesity and Lysosomal Dysfunction on Chemoresistance in Ovarian Cancer
by: Boyun Kim, et al.
Published: (2024-03-01)

Association of common glutathione transferase polymorphisms with ovarian cancer risk and chemoresistance
by: Simić Petar, et al.
Published: (2024-01-01)

Prediction of Chemoresistance—How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer
by: Jacek Wilczyński, et al.
Published: (2023-12-01)

Adipocyte pyroptosis occurs in omental tumor microenvironment and is associated with chemoresistance of ovarian cancer
by: Chang-Ni Lin, et al.
Published: (2024-06-01)

Advances and challenges in the origin and evolution of ovarian cancer organoids
by: Mengpei Zhang, et al.
Published: (2024-08-01)

Ovarian cancer ascites confers platinum chemoresistance to ovarian cancer cells
by: Yifat Koren Carmi, et al.
Published: (2024-06-01)

SPL-108 mitigates metastasis and chemoresistance in tubo-ovarian carcinoma
by: Olivia D. Lara, et al.
Published: (2025-01-01)

FGF19 promotes cell autophagy and cisplatin chemoresistance by activating MAPK signaling in ovarian cancer
by: Wei Zhu, et al.
Published: (2023-02-01)

In vitro drug testing using patient-derived ovarian cancer organoids
by: Lin-Yu Chen, et al.
Published: (2024-10-01)

Research on uPAR promoting proliferation, migration, and chemoresistance of pancreatic cancer by inhibiting autophagy via MAPK signaling
by: TAN Xiaolang, YAO Sha, WANG Guihua, PENG Luogen
Published: (2024-10-01)

A novel TCGA-validated programmed cell-death-related signature of ovarian cancer
by: Xintong Cai, et al.
Published: (2024-04-01)

Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression and chemoresistance by enhancing the secretion of chemotherapy-induced senescence-associated secretory phenotype via activation of DNA damage response pathway
by: Jian-Wei Zhang, et al.
Published: (2023-12-01)

HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process
by: Sijia Ma, et al.
Published: (2024-02-01)

Patient‐derived ovarian cancer organoid carries immune microenvironment and blood vessel keeping high response to cisplatin
by: Yuqing Zhao, et al.
Published: (2024-09-01)

Defects of mitochondria-lysosomes communication induce secretion of mitochondria-derived vesicles and drive chemoresistance in ovarian cancer cells
by: Sinforosa Gagliardi, et al.
Published: (2024-03-01)

Research advances in the construction of stem cell-derived ovarian organoids
by: Tianyue Zhang, et al.
Published: (2024-12-01)

Patient‐derived organoid culture in epithelial ovarian cancers—Techniques, applications, and future perspectives
by: Wai Sun Chan, et al.
Published: (2023-10-01)

Frizzled class receptor 5 contributes to ovarian cancer chemoresistance through aldehyde dehydrogenase 1A1
by: Yuhong Xia, et al.
Published: (2024-03-01)

Identification and Evaluation of Survival-associated Common Chemoresistant Genes in Cancer
by: Mansi Patel, et al.
Published: (2024-09-01)

Biochemical and transcriptomic evaluation of a 3D lung organoid platform for pre-clinical testing of active substances targeting senescence
by: Michelle Brand, et al.
Published: (2024-01-01)

Exploration of organoids in ovarian cancer: From basic research to clinical translation
by: Siyu Li, et al.
Published: (2024-12-01)

Exosome-transmitted LUCAT1 promotes stemness transformation and chemoresistance in bladder cancer by binding to IGF2BP2
by: Yonghao Zhan, et al.
Published: (2025-03-01)

Determination of chemoresistance of ovarian cancer cells in vitro
by: K. A. Kuzin, et al.
Published: (2019-12-01)

TCEB2/HIF1A signaling axis promotes chemoresistance in ovarian cancer cells by enhancing glycolysis and angiogenesis
by: Zhuo Deng, et al.
Published: (2024-09-01)

Progress in the development of ovarian cancer organoids and their application in drug testing
by: Dong CHEN, et al.
Published: (2021-08-01)

Plasma Gelsolin Inhibits Natural Killer Cell Function and Confers Chemoresistance in Epithelial Ovarian Cancer
by: Toshimichi Onuma, et al.
Published: (2024-05-01)

BIRC5 facilitates cisplatin‐chemoresistance in a m6A‐dependent manner in ovarian cancer
by: Yadan Fan, et al.
Published: (2024-01-01)

Genetically inspired organoids prevent joint degeneration and alleviate chondrocyte senescence via Col11a1–HIF1α‐mediated glycolysis–OXPHOS metabolism shift
by: Ye Sun, et al.
Published: (2024-02-01)

A multiomics comparison between endometrial cancer and serous ovarian cancer
by: Hui Zhong, et al.
Published: (2020-01-01)

Editorial: Mechanobiology of organoid systems
by: Shijie He, et al.
Published: (2024-01-01)

Establishment of Stable Knockdown of MACC1 Oncogene in Patient-Derived Ovarian Cancer Organoids
by: Sophia Hierlmayer, et al.
Published: (2024-12-01)

Molecular characteristics and tumorigenicity of ascites‐derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer
by: Yi Ding, et al.
Published: (2021-12-01)

Unveiling senescence-associated ocular pathogenesis via lacrimal gland organoid magnetic bioassembly platform and HMGB1-Box A gene therapy
by: Joao Nuno Ferreira, et al.
Published: (2024-09-01)

Exploring the relationship between anastasis and mitochondrial ROS-mediated ferroptosis in metastatic chemoresistant cancers: a call for investigation
by: Yu Cao, et al.
Published: (2024-07-01)

Prognostic values of GMPS, PR, CD40, and p21 in ovarian cancer
by: Ping Wang, et al.
Published: (2019-01-01)

Ataxia Telangiectasia patient-derived neuronal and brain organoid models reveal mitochondrial dysfunction and oxidative stress
by: Hannah C. Leeson, et al.
Published: (2024-09-01)

Inhibition of the E3 ligase UBR5 stabilizes TERT and protects vascular organoids from oxidative stress
by: Haijing Zhao, et al.
Published: (2024-11-01)